search index hum-molgen

 

HUM-MOLGEN events
RECOMBINANT ANTIBODIES
 
Cambridge Healthtech Institute , Baltimore, Maryland
June 5-6, 2000

Antibody therapeutics hold the promise of effective treatment for some of the most significant unmet clinical needs, including cancer, HIV, autoimmune diseases, infectious disease, neuromuscular disease, vascular disease, organ rejection, and allergic disease. Research is revealing more about the basic science of antibodies and their use as powerful therapeutics. This conference will present the latest data on topics relating to recombinant antibodies and their potential in the treatment of disease. It will also explore the latest results from pre-clinical and clinical trials of antibody-based therapeutics.

Organized by:

Cambridge Healthtech Institute

Deadline for Abstracts:

April 28, 2000

Registration:

Email for Requests and Registration: jlaakso@healthtech.com
 
 

Posted by: Jennifer Laakso   Host: 140.239.39.137
date: January 20, 2000 15:30:37
Generated by meetings and positions 2.0 by Kai Garlipp
Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany.
4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.